Skip to Main Content

Paper Details

Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol.
BMJ Open
1
2023
Author NameAffiliation
Christopher M HovensRoyal Melbourne Hospital, The University of Melbourne
  • 1 - 1

Datasets

Release 1.2